Laurus Labs Limited — Capital/Financing Update 2025

Dec 23, 2025

December 23, 2025

==> picture [190 x 81] intentionally omitted <==

ToThe Corporate Relations DepartmentBSE LimitedPhiroze Jeejeebhoy Towers,Dalal Street,Mumbai – 400 001Code: 540222	ToThe Listing DepartmentNational Stock Exchange of India Ltd.,Exchange Plaza,Bandra Kurla Complex, Bandra (E),Mumbai – 400 051Code: LAURUSLABS

Sub: Update on proposed equity investment in KRKA Pharma Private Limited under Regulation 30(7) of SEBI (LODR) Regulations, 2015

Ref: Our intimation letter dated 25[th] July, 2025

Dear Sir / madam,

In continuation to our letter dated July 25, 2025 with regard to proposed acquisition of equity shares in KRKA Pharma Private Limited (“KRKA”) (a joint venture of the Company) and as per Regulation 30(7) of SEBI (LODR) Regulations, 2015, we would like to inform you that the Company has invested INR 490,000,000/- (Indian Rupees Four Hundred and Ninety Million only) and acquired 49,000,000 (Forty Nine Million) equity shares of KRKA at face value of INR 10/each aggregating to an amount of INR 490,000,000/- (Indian Rupees Four Hundred and Ninety Million only) by way of rights issue.

Please take the above information on record.

Yours faithfully,

For Laurus Labs Limited

VENKATESWAR Digitally signed by VENKATESWAR REDDY REDDY GOGIREDDY GOGIREDDY Date: 2025.12.23 16:06:32 +05'30'

G. Venkateswar Reddy

Company Secretary & Compliance Officer

==> picture [453 x 76] intentionally omitted <==